What is the appropriate initial work‑up and management for a 24‑year‑old woman with fatigue, migraines, mild thrombocytosis and mild leukocytosis?

Initial Work-Up and Management

In a 24-year-old woman with fatigue, migraines, mild thrombocytosis, and mild leukocytosis, the most critical first step is to obtain a peripheral blood smear reviewed by a hematopathologist to exclude pseudothrombocytopenia, assess platelet and leukocyte morphology, and rule out myeloproliferative disorders or reactive causes—particularly iron deficiency anemia, which can produce this exact constellation of findings. 1, 2

Step 1: Confirm True Cytosis and Exclude Laboratory Artifact

• Repeat the complete blood count in a citrate or heparin tube if EDTA-dependent platelet clumping is suspected, as pseudothrombocytopenia occurs in approximately 0.1% of samples and must be ruled out before any further evaluation 1, 2
• Request manual peripheral blood smear examination by a qualified hematopathologist to identify:
  • Giant platelets (megathrombocytes), which suggest inherited thrombocytopenia or bone marrow disorders 1, 3
  • Microcytosis or hypochromic red cells, which point to iron deficiency 4
  • Immature granulocytes or dysplastic features, which raise concern for myeloproliferative neoplasms 5
  • Normal platelet size and absence of schistocytes to support reactive thrombocytosis 1

Step 2: Essential Laboratory Evaluation

Core hematologic tests:

• Iron studies (serum iron, ferritin, total iron-binding capacity, transferrin saturation) – iron deficiency anemia is the most common cause of combined thrombocytosis and leukocytosis in young women and can produce platelet counts exceeding 1000 × 10⁹/L 4
• Reticulocyte count – to assess bone marrow response and distinguish iron deficiency from other causes of microcytic anemia 1
• Comprehensive metabolic panel – to evaluate renal function, electrolytes, and liver enzymes 5
• Lactate dehydrogenase (LDH) – elevated in hemolysis, myeloproliferative disorders, and tissue breakdown 5

Mandatory infectious disease screening:

• HIV antibody testing – HIV can cause cytopenias or reactive leukocytosis and must be excluded in all adults with unexplained hematologic abnormalities 1
• Hepatitis C virus serology – chronic HCV can produce thrombocytosis or thrombocytopenia and systemic symptoms 1

Additional context-specific tests:

• C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) – to assess for inflammatory or infectious processes causing reactive thrombocytosis 4
• Thyroid-stimulating hormone (TSH) – thyroid dysfunction can cause fatigue and has been associated with hematologic abnormalities 1
• Pregnancy test – in women of childbearing age to exclude pregnancy-related causes of fatigue and hematologic changes 1

Step 3: Assess for Myeloproliferative Neoplasms (If Iron Studies Are Normal)

• JAK2 V617F mutation testing – present in >95% of polycythemia vera cases and 50-60% of essential thrombocythemia cases; this is the single most important test to exclude clonal thrombocytosis 5
• Serum erythropoietin level – low or low-normal EPO suggests polycythemia vera, even with borderline-high hematocrit 5
• Peripheral blood BCR-ABL1 fusion gene by RT-PCR – to exclude chronic myeloid leukemia, which can present with leukocytosis and thrombocytosis 5

Step 4: Bone Marrow Examination—When Required

Bone marrow aspiration and biopsy with cytogenetics and flow cytometry are mandatory if any of the following are present 1, 3:

• Persistent unexplained thrombocytosis (>450 × 10⁹/L) or leukocytosis (>11 × 10⁹/L) after excluding reactive causes
• Giant platelets (megathrombocytes) on peripheral smear
• Splenomegaly, hepatomegaly, or lymphadenopathy on physical examination
• Constitutional symptoms (fever, night sweats, unintentional weight loss >10% body weight)
• Abnormal red cell morphology or immature granulocytes on smear
• Failure to correct cytopenias or cytoses after treating iron deficiency

Bone marrow examination is NOT required if iron deficiency is confirmed and cytopenias/cytoses resolve with iron supplementation 1, 4

Step 5: Migraine Evaluation in the Context of Hematologic Findings

• Migraines in the setting of thrombocytosis warrant specific attention, as platelet dysfunction and abnormal serotonin metabolism have been implicated in migraine pathogenesis 6, 7
• If essential thrombocythemia is diagnosed, headache symptoms may improve with cytoreductive therapy (hydroxyurea or anagrelide) 7, 8
• Exclude secondary causes of headache:
  • Intracranial hypotension (if orthostatic component) 5
  • Cerebral venous thrombosis (if thrombocytosis is due to myeloproliferative disorder) 5
  • HaNDL syndrome (headache with neurologic deficits and CSF lymphocytosis) if focal neurologic symptoms are present 9

Step 6: Management Algorithm Based on Findings

If iron deficiency anemia is confirmed:

• Initiate oral iron supplementation (elemental iron 150-200 mg daily in divided doses) 3, 4
• Investigate the source of iron loss (menorrhagia, gastrointestinal bleeding, dietary insufficiency) 3
• Recheck CBC in 4-6 weeks; thrombocytosis and leukocytosis should normalize within 2-3 months of iron repletion 4

If myeloproliferative neoplasm is diagnosed:

• Refer to hematology-oncology for risk stratification and initiation of cytoreductive therapy 5, 8
• For symptomatic thrombocytosis (platelet count >1000 × 10⁹/L with headache or neurologic symptoms), consider urgent therapeutic plateletpheresis as a bridge to pharmacologic therapy 8

If all testing is normal:

• Reassess in 3 months with repeat CBC and peripheral smear 5
• Continue symptomatic management of migraines with standard therapies 7
• Educate the patient on warning signs requiring urgent evaluation (fever, severe headache, visual changes, bleeding, thrombosis) 1

Critical Pitfalls to Avoid

• Never diagnose a myeloproliferative disorder without hematopathologist review of the peripheral smear, as automated counters miss giant platelets and dysplastic features 1, 2
• Never omit iron studies in a young woman with thrombocytosis and leukocytosis, as iron deficiency is the most common reversible cause and can produce extreme elevations (platelets >2000 × 10⁹/L) 4
• Never assume migraines are unrelated to hematologic findings; thrombocytosis from essential thrombocythemia or polycythemia vera can directly cause or worsen headaches through abnormal platelet aggregation and serotonin release 6, 7
• Never delay bone marrow examination if constitutional symptoms, organomegaly, or persistent unexplained cytoses are present, as missing a myeloproliferative neoplasm or acute leukemia has catastrophic mortality implications 5, 1